Follow our path with asparaginase activity: one technique, but different uses in clinical practice

Follow our path with asparaginase activity: one technique, but different uses in clinical practice

Abstract Acute lymphoblastic leukemia is the most common childhood malignancy. One of the drugs used in the treatment is Asparaginase, and monitoring of its activity levels enables better outcomes. Since 2018, our laboratory has been working to establish a regular analysis of activity. This implemen...

Full description

Bibliographic Details
Main Authors: Daiane Keller Cecconello, Ciliana Rechenmacher, Klerize Anecely de Souza Silva, Fernanda Fetter Scherer, Thomas Dal Bem Prates, Rebeca Ferreira Marques, Liane Esteves Daudt, Mariana Bohns Michalowski
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Experimental Hematology & Oncology
Subjects:
Acute lymphoblastic leukemia
PEG asparaginase
Enzimatic activity
Desensitization protocols
Online Access:https://doi.org/10.1186/s40164-022-00351-5

Internet

https://doi.org/10.1186/s40164-022-00351-5

Similar Items